ESBL E. coli carriers
Conditions
Interventions
A probiotic capsule,
contain Saccharomyces boulardii 282.5 mg each. FDA number 1C391/49 ,Made to looked,
smelled,
tested like Bioflor capsule. Contain only maltodextrin. No medical effect.
Bioflor 250 (CAPSULES),Placebo
Sponsors
Department of Microbiology, Phramongkutklao College of Medicine
Department of Pharmacology,
Phramongkutklao College of Medicine
Eligibility
Sex/Gender
All
Age
19 Years to No maximum
Inclusion criteria
Inclusion criteria: - living in Phrapleng community, Sa Keaw Province, Thailand - age over 18 years old - Stool culture positive for ESBL E. coli - consent to participate in the research
Exclusion criteria
Exclusion criteria: - Immunocompromised host eg. AIDs, immunosuppressant users etc. - consummation of active microbiota food eg. curd, yogurt etc. at the time of intervention carry (3 weeks) - taking antibiotics that effect ESBL bacteria; Carbapenems, Beta-lactamase inhibitor and Aminoglycosides at the time of intervention carry (3 weeks)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| prevalence of ESBL E. coli carriers after intervention in both groups of participants before and after intervention Screening test by stool culture on selective ESBL agar, confirmatory test by MALDI-TOF and combine | — |
Secondary
| Measure | Time frame |
|---|---|
| N/A N/A N/A | — |
Countries
Thailand
Contacts
Public ContactPiyanete Kesakomol
Phramongkutklao college of medicine
Outcome results
None listed